Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Frenkel LD, Bellanti JA. Monkeypox viral infection and disease: A challenge for the allergist-immunologist. Allergy Asthma Proc 2022;43:509-518. [PMID: 36335412 DOI: 10.2500/aap.2022.43.220075] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]

For:	Frenkel LD, Bellanti JA. Monkeypox viral infection and disease: A challenge for the allergist-immunologist. Allergy Asthma Proc 2022;43:509-518. [PMID: 36335412 DOI: 10.2500/aap.2022.43.220075] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]

Number	Cited by Other Article(s)
1	Bellanti JA, Settipane RA. A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors. Allergy Asthma Proc 2022;43:471-473. [PMID: 36335419 PMCID: PMC9645732 DOI: 10.2500/aap.2022.43.220081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Abstract Collapse Key Words Collapse MESH Headings Humans Dermatitis, Atopic/drug therapy Chronic Urticaria Janus Kinase Inhibitors/therapeutic use Biological Products/therapeutic use Urticaria/drug therapy Eosinophilia/drug therapy Lung Diseases Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Bellanti JA, Settipane RA. A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors. Allergy Asthma Proc 2022;43:471-473. [PMID: 36335419 PMCID: PMC9645732 DOI: 10.2500/aap.2022.43.220081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]